Primary Peritoneal Cancer
Links shared publicly online about this topic
GOG to conduct Phase II trial on primary peritoneal cancer
news-medical.net — “Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN(R) in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).” View full resource at news-medical.net
Most Recently Shared on September 3, 2010 at 10:59 am By:
GOG to conduct Phase II trial on primary peritoneal cancer: Oncolytics Biotech Inc. announced today that the Gynec... http://bit.ly/9nWzJ7
ScienceDirect - Gynecologic Oncology : A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group
sciencedirect.com — “ScienceDirect - Gynecologic Oncology : A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study” View full resource at sciencedirect.com
Most Recently Shared on May 31, 2011 at 4:15 am By:
Paul Cacciatore Patient Advocate
GOG ph. 2 study: M.D. Anderson finds wkly nab-paclitaxel has clinical efficacy in resistant/refractory ovarian cancer. http://dld.bz/abFcJ
Peritoneal Cancers " Malignant Mesothelioma and Ovarian Cancer
cancer.suite101.com — “Primary Peritoneal Cancers or PPCs are primary cancers that originate within the peritoneum. PPCs have been implicated in mesothelioma & ovarian cancers.” View full resource at cancer.suite101.com
Most Recently Shared on April 12, 2010 at 1:52 am By:
Peritoneal Cancers -- Malignant Mesothelioma and Ovarian Cancer: Primary Peritoneal Cancers or PPCs are primary ca... http://bit.ly/bKe507
Primary Squamous Cell Carcinoma of the Urinary Bladder Presenting as Peritoneal Carcinomatosis
hindawi.com — “We report an unusual case of a 78-year-old Caucasian female, who presented with peritoneal carcinomatosis and hypercalcemia, and was found to have a rapidly progressive primary squamous cell carcinoma of the urinary bladder. Squamous cell bladder carcinoma is a rare malignancy in the United States, accounting for just 1"3% of bladder tumors. Interestingly our patient lacked the established risk factors, including exposure to the parasite Schistosoma haematobium, recurrent urinary tract infection” View full resource at hindawi.com
Most Recently Shared on June 28, 2010 at 11:22 am By:
Primary Squamous Cell Carcinoma of the Urinary Bladder Presenting as Peritoneal Carcinomatosis: We report an unusu... http://bit.ly/cc3UtR
Oncology Article | Ovarian Neoplasms Peritoneal Neoplasms
mdlinx.com — “Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer” View full resource at mdlinx.com
Most Recently Shared on April 6, 2011 at 7:39 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer:... http://bit.ly/fQuTsB #oncology
Peritoneal Cancer: Prognosis, Symptoms, and Treatments
webmd.com — “WebMD explains what peritoneal cancer is as well as prognosis and treatments for this type of cancer.” View full resource at webmd.com
Most Recently Shared on September 13, 2010 at 4:35 pm By:
Peritoneal Cancer: Prognosis, Symptoms, and Treatments http://bit.ly/9FxK69
European Journal of Human Genetics - Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk
nature.com — “The European Journal of Human Genetics is the official Journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports, News and Commentary articles and reviews in the rapidly expanding field of human genetics and genomics.” View full resource at nature.com
Most Recently Shared on October 22, 2009 at 5:27 pm By:
Mark Robson Physician, Doctor, Internist, Oncologist, and Hematologist
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk http://bit.ly/15DFks
Oncology Article | Carcinoma Ovarian Neoplasms Peritoneal Neoplasms
mdlinx.com — “Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A gynecologic oncology group trial” View full resource at mdlinx.com
Most Recently Shared on November 24, 2010 at 6:57 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A gynecologic... http://bit.ly/hmPEF6 #oncology
Ob/Gyn Article | Carcinoma Ovarian Neoplasms Peritoneal Neoplasms
mdlinx.com — “Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A gynecologic oncology group trial” View full resource at mdlinx.com
Most Recently Shared on November 25, 2010 at 2:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A gynecologic on... http://bit.ly/hxN8AI #OBGYN
Peritoneal Mesothelioma Information
disabled-world.com — “Peritoneal Mesothelioma is a rare fatal cancer of the abdominal lining usually associated with asbestos exposure” View full resource at disabled-world.com
Most Recently Shared on October 9, 2010 at 6:42 pm By:
Disabled World Health Advocate and Health News
Peritoneal Mesothelioma Information http://ff.im/-rMiO9
Oncology Medical News about Fallopian Tube Neoplasms Ovarian Neoplasms Peritoneal Neoplasms
mdlinx.com — “Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer” View full resource at mdlinx.com
Most Recently Shared on February 8, 2010 at 8:05 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube can... http://bit.ly/adh3i3
ScienceDirect - Gynecologic Oncology : Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
sciencedirect.com — “ScienceDirect - Gynecologic Oncology : Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma” View full resource at sciencedirect.com
Most Recently Shared on May 31, 2011 at 4:30 am By:
Paul Cacciatore Patient Advocate
Mayo Clinic finds lapatinib + topotecan 4 treatment of plat. refrac/resist ovarian cancer lacks sufficient activity. http://dld.bz/abFdq
Oncology Article | Ovarian Neoplasms Carcinoma Peritoneal Neoplasms
mdlinx.com — “The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: A 16-year institutional review” View full resource at mdlinx.com
Most Recently Shared on November 5, 2010 at 9:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary perito... http://bit.ly/cxf80h #oncology
Tuberculous peritonitis in a German patient with primary biliary cirrhosis: a case report | Gastroenterology
touchgastroenterology.com — “Title: Tuberculous peritonitis in a German patient with primary biliary cirrhosis: a case reportshort title: Tuberculous peritonitis in a GermanShort summary: Abstract: Background: The number of cases of tuberculosis” View full resource at touchgastroenterology.com
Most Recently Shared on June 14, 2011 at 1:07 pm By:
touchGASTRO Gastroenterology and Medical Journal
Tuberculous peritonitis in a German patient with primary biliary cirrhosis: a case report http://bit.ly/j1UKyy #gastroenterology
Tipping the Balance for the Primary Prevention of Breast Cancer " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Tipping the Balance for the Primary Prevention of Breast Cancer " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on November 5, 2010 at 3:48 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
"Lasofoxifene appears to represent an advance in the progression of pharmacological agents at our disposal, which... http://fb.me/AgrzyGGT
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
Paul Cacciatore
Founder of Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
-
HealthPassion
Follow your Health Passion Here! We will be feeding all Health News, Updates, Tips and Reviews. We hope to help you pursue and follow your Passion.
Advertisement
